- PDAC (Pricing, Data Analysis and Coding) contractor-verified for Medicare reimbursement: Code E0486
- More than 400,000 Silent Nite Sleep Appliances delivered
- Optional "One for Relief, One for Reserve" Glidewell Clinical Twinpak™ helps ensure patients never go untreated
- Each case includes an AM Aligner® and extra connectors
Silent Nite® Sleep Appliance
$190*
*Price is per appliance and does not include shipping or applicable taxes.
Please note pricing is only available to dental professionals.
Helping patients achieve a deeper, more satisfying night’s sleep, the Silent Nite® Sleep Appliance treats sleep-disordered breathing quickly and effectively.
Stop Snoring. Start Living!
Helping patients achieve a deeper, more satisfying night’s sleep, the Silent Nite Sleep Appliance is flexible, thin and comfortable, and it exhibits documented clinical success in mitigating or preventing the disruptive, unhealthy effects of snoring and mild to moderate sleep apnea. The Silent Nite appliance is designed to gently shift the lower jaw forward in a therapeutic position during sleep, which activates the airway muscles and ligaments to prevent the airway from collapsing. Each Silent Nite case includes extra connectors, in various sizes, and an AM Aligner to aid patients in exercising and realigning the jaw after nighttime mandibular advancement.
PDAC-Approved for Medicare: E0486
The Silent Nite Sleep Appliance is eligible for Medicare reimbursement under code E0486. This benefit further expands opportunities for dentists to provide therapy to patients suffering from snoring and mild to moderate obstructive sleep apnea.
AM Aligner is a registered trademark of Airway Technologies, LLC.
Patient Satisfaction
Oral appliance therapy (OAT) is very effective in treating patients with sleep-disordered breathing, with a compliance rate shown to be as high as 90% over a 2.5-year period.1
OAT is associated with greater patient satisfaction than nasal continuous positive airway pressure (CPAP) therapy.2
In a randomized crossover trial comparing OAT to CPAP in patients with obstructive sleep apnea, about 81% preferred OAT.3
Improved Health
Among patients with obstructive sleep apnea, both continuous positive airway pressure (CPAP) and mandibular advancement devices (MADs) were associated with reductions in blood pressure. Network meta-analysis did not identify a statistically significant difference between the blood pressure outcomes associated with these therapies.4
A mandibular advancement device for obstructive sleep apnea reduces nocturnal blood pressure in women.5
Patient Satisfaction
Do you want to learn about providing provisional oral appliance therapy? The legal document “Informed Consent for Silent Nite — Provisional Mandibular Advancement Device” from dentist-attorney Dr. Ken Berley is available for free download, containing important information for both providers and patients.
On the first night of using my Silent Nite appliance, I was so quiet that my wife actually checked to make sure I was still breathing.
My Silent Nite fits like a glove, and I can’t fall asleep without it. I have better sleep, mental focus, and I’m more alert.
- Slide 1
- Slide 2
Indications
The Silent Nite Sleep Appliance is indicated to reduce snoring and mild to moderate obstructive sleep apnea (OSA) in patients 18 years of age or older. The appliance is worn while sleeping to support the lower jaw in a forward position as determined by the dentist. The appliance is removable by the patient.
Material Composition
Soft inner layer with a hard, durable outer layer, both of which are BPA-free
Number of Appliances Delivered
400,000
In-Lab Working Times
3 days
Available Colors
Clear
Pricing
|
Silent Nite(3 days in lab) (PDAC-approved) (buy 1)
|
$190.001 |
|
Glidewell Clinical Twinpak(buy 2)2
|
$262.001 |
1
Digital file storage is available for this product. See Scan & Save Services.
2
Glidewell Clinical Twinpak is valid for two appliances for the same case.
For more information on our Scan & Save services, call us at 800-407-3326.
Pricing is subject to change and does not include shipping or applicable taxes.
Policies & Warranty
NO-FAULT REMAKE POLICY: Glidewell is pleased to process all remakes or adjustments at no additional charge if requested within the warranty period and accompanied by the return of the original appliance.
LIMITED WARRANTY/LIMITATION OF LIABILITY. Glidewell (“the lab”) warrants that all dental devices (a “device”) are made according to your specification and approval in the belief that the device will be useful and MAKES NO OTHER WARRANTIES INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Subject to the return of a device that is placed and then fails, the lab will repair or replace the device without charge for the cost of materials and workmanship or refund the original price paid, at the lab’s option, for up to 3 years for the Silent Nite Sleep Appliance.
Procedures
Loading results...
Additional Resources
Literature
Loading results...
References
- ^ Yoshida K. Effects of a mandibular advancement device for the treatment of sleep apnea syndrome and snoring on respiratory function and sleep quality. Cranio. 2000 Apr;18(2):98-105.
- ^ Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs. nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest. 1996 May;109(5):1269-75.
- ^ Tan YK, L’Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, Spiro SG, Battagel JM. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod. 2002 Jun;24(3):239-49.
- ^ Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs. mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015 Dec 1;314(21):2280-93.
- ^ Rietz H, Franklin KA, Carlberg B, Sahlin C, Marklund M. Nocturnal blood pressure is reduced by a mandibular advancement device for sleep apnea in women: findings from secondary analyses of a randomized trial. J Am Heart Assoc. 2018 Jun 21;7(13).
